Predictive value of a preoperative biochemical bone marker in relation to bone remodeling after cementless total hip arthroplasty.
To identify the factors predicting proximal bone resorption of the femur after cementless total hip arthroplasty (THA), we studied 24 postmenopausal women with osteoarthritis. Periprosthetic bone mineral density (BMD) measurements of the seven Gruen zones were determined with dual-energy X-ray absorptiometry at 3 wk, 6, 12, and 18 mo after operation. The greatest decrease in BMD (13.2%) was found in zone 7 at 18 mo. At 18 mo, preoperative serum bone alkaline phosphatase was associated univariately with BMD loss in zones 1 (r = 0.407, p = 0.048) and 7 (r = 0.543, p = 0.006) and urinary N-telopeptide cross-linked collagen type I (NTX) was associated univariately with that in zone 7 (r = 0.520, p = 0.009). Patient age correlated with BMD loss in zone 7 (r = 0.425, p = 0.039). Multiple regression analysis identified a significant relationship between the BMD loss and patient age and NTX in zone 7 at 18 mo (r2 = 0.422, p = 0.001). We conclude that preoperative bone markers are significant predictors of bone remodeling after THA with the particular implants used in our study.
D015502:Absorptiometry, Photon; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood*; D019644:Arthroplasty, Replacement, Hip; D015519:Bone Density; D016723:Bone Remodeling; D003094:Collagen / Q000652:urine*; D024042:Collagen Type I; D005260:Female; D006801:Humans; D008875:Middle Aged; D015207:Osteoarthritis, Hip / Q000601:surgery; D010455:Peptides / Q000652:urine*; D011184:Postoperative Period; D011237:Predictive Value of Tests
D024042:Collagen Type I; D010455:Peptides; C052929:collagen type I trimeric cross-linked peptide; D003094:Collagen; D000469:Alkaline Phosphatase